2 August 2017 - Deborah Wilkes
Archived
Pfizer Consumer Healthcare's sales in the second quarter of 2017 fell by 3% in the US but rose by 7% in international markets on an operational basis.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.